Venture Life Group plc (AIM:VLG)

Market Cap	68.83M +32.7%
Revenue (ttm)	35.17M +264.0%
Net Income	6.13M +725.5%
EPS	0.05 +782.5%
Shares Out	121.83M
PE Ratio	11.24
Forward PE	13.78
Dividend	n/a
Ex-Dividend Date	n/a

Volume	257,710
Average Volume	189,240
Open	56.00
Previous Close	56.50
Day's Range	55.00 - 57.00
52-Week Range	44.50 - 72.00
Beta	0.24
RSI	14.92
Earnings Date	May 13, 2026

About Venture Life Group

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms rela...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2005
• Employees: 43
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: VLG